The emergence and successful elimination of SARS-CoV-2 dominant strains with increasing epidemic potential in Taiwan’s 2021 outbreak

Taiwan’s experience with severe acute respiratory syndrome coronavirus (SARS-CoV) in 2003 guided its development of strategies to defend against SARS-CoV-2 in 2020, which enabled the successful control of Coronavirus disease 2019 (COVID-19) cases from 2020 through March 2021. However, in late-April...

Full description

Saved in:
Bibliographic Details
Published inHeliyon Vol. 9; no. 12; p. e22436
Main Authors Yang, Chin-Rur, Chang, Sui-Yuan, Gong, Yu-Nong, Huang, Chung-Guei, Tung, Tsung-Hua, Liu, Wei, Chan, Ta-Chien, Hung, Kuo-Sheng, Shang, Hung-Sheng, Tsai, Jih-Jin, Kao, Chuan-Liang, Wu, Hui-Lin, Daisy Liu, Li-Yu, Lin, Wan-Yu, Fan, Yi-Chin, King, Chwan-Chuen, Ku, Chia-Chi
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.12.2023
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Taiwan’s experience with severe acute respiratory syndrome coronavirus (SARS-CoV) in 2003 guided its development of strategies to defend against SARS-CoV-2 in 2020, which enabled the successful control of Coronavirus disease 2019 (COVID-19) cases from 2020 through March 2021. However, in late-April 2021, the imported Alpha variant began to cause COVID-19 outbreaks at an exceptional rate in Taiwan. In this study, we aimed to determine what epidemiological conditions enabled the SARS-CoV-2 Alpha variant strains to become dominant and decline later during a surge in the outbreak. In conjunction with contact-tracing investigations, we used our bioinformatics software, CoVConvert and IniCoV, to analyze whole-genome sequences of 101 Taiwan Alpha strains. Univariate and multivariable regression analyses revealed the epidemiological factors associated with viral dominance. Univariate analysis showed the dominant Alpha strains were preferentially selected in the surge’s epicenter (p = 0.0024) through intensive human-to-human contact and maintained their dominance for 1.5 months until the Zero-COVID Policy was implemented. Multivariable regression found that the epidemic periods (p = 0.007) and epicenter (p = 0.001) were two significant factors associated with the dominant virus strains spread in the community. These dominant virus strains emerged at the outbreak’s epicenter with frequent human-to-human contact and low vaccination coverage. The Level 3 Restrictions and Zero-COVID policy successfully controlled the outbreak in the community without city lockdowns. Our integrated method can identify the epidemiological conditions for emerging dominant virus with increasing epidemiological potential and support decision makers in rapidly containing outbreaks using public health measures that target fast-spreading virus strains. This figure summarizes our major findings in this study. Before the outbreak (T0, Pre-outbreak), the imported Alpha variant strains were heterogeneous with high viral genome divergence. However, such diversity significantly decreased during the T1 period (versus T0, p < 0.0001), when the dominant virus strains with selective advantages appeared. We also investigated the epidemiological conditions in Taiwan that facilitated the emergence of the predominant virus strain in the T1 period. The effective reproductive numbers over time (Rt) for the viruses from the imported cases were all zero at T0 period before the outbreak. However, the mean Rt values of the viruses from the pilots to quarantine hotel staff and subsequent dominant virus strains in the community (i.e. same sequence identities as the ID-3445/1263/1186) increased rapidly. Specific epidemiological conditions, including unmasked dining in many teahouses, and customers’ movement across teahouses, helped the dominant Alpha variant strains with a selective advantage. This study demonstrated that natural selection of a dominant virus strain (prior to immune selection) progressed in three stages: (1) selection started from a diverse virus pool (i.e. imported viruses at T0), (2) selection advantages increased through virus replication, in which the progeny virus had more advantages than its parent virus, and (3) selection of a fast-spreading virus strain through human-to-human transmission when a community had suitable epidemiological conditions (i.e. our T1 period and epicenter). Most importantly, COVID-19 cases dropped sharply alongside the two important population-intervention strategies (Level 3 Restrictions and Zero-COVID policy). [Display omitted] •Frequent human-to-human contact at the epicenter selected dominant SARS-CoV-2 strains.•Dominant SARS-CoV-2 strains had the highest Rt values under specific epidemiological conditions.•Level 3 Restrictions and Zero-COVID Policy were effective without lockdown.•Individual- and population-based prevention measures contained fast-spreading dominant virus strains.•Preventing cluster cases that would have aided viral selection effectively defended against VOCs.
AbstractList Taiwan’s experience with severe acute respiratory syndrome coronavirus (SARS-CoV) in 2003 guided its development of strategies to defend against SARS-CoV-2 in 2020, which enabled the successful control of Coronavirus disease 2019 (COVID-19) cases from 2020 through March 2021. However, in late-April 2021, the imported Alpha variant began to cause COVID-19 outbreaks at an exceptional rate in Taiwan. In this study, we aimed to determine what epidemiological conditions enabled the SARS-CoV-2 Alpha variant strains to become dominant and decline later during a surge in the outbreak. In conjunction with contact-tracing investigations, we used our bioinformatics software, CoVConvert and IniCoV, to analyze whole-genome sequences of 101 Taiwan Alpha strains. Univariate and multivariable regression analyses revealed the epidemiological factors associated with viral dominance. Univariate analysis showed the dominant Alpha strains were preferentially selected in the surge’s epicenter (p = 0.0024) through intensive human-to-human contact and maintained their dominance for 1.5 months until the Zero-COVID Policy was implemented. Multivariable regression found that the epidemic periods (p = 0.007) and epicenter (p = 0.001) were two significant factors associated with the dominant virus strains spread in the community. These dominant virus strains emerged at the outbreak’s epicenter with frequent human-to-human contact and low vaccination coverage. The Level 3 Restrictions and Zero-COVID policy successfully controlled the outbreak in the community without city lockdowns. Our integrated method can identify the epidemiological conditions for emerging dominant virus with increasing epidemiological potential and support decision makers in rapidly containing outbreaks using public health measures that target fast-spreading virus strains.
Taiwan's experience with severe acute respiratory syndrome coronavirus (SARS-CoV) in 2003 guided its development of strategies to defend against SARS-CoV-2 in 2020, which enabled the successful control of Coronavirus disease 2019 (COVID-19) cases from 2020 through March 2021. However, in late-April 2021, the imported Alpha variant began to cause COVID-19 outbreaks at an exceptional rate in Taiwan. In this study, we aimed to determine what epidemiological conditions enabled the SARS-CoV-2 Alpha variant strains to become dominant and decline later during a surge in the outbreak. In conjunction with contact-tracing investigations, we used our bioinformatics software, CoVConvert and IniCoV, to analyze whole-genome sequences of 101 Taiwan Alpha strains. Univariate and multivariable regression analyses revealed the epidemiological factors associated with viral dominance. Univariate analysis showed the dominant Alpha strains were preferentially selected in the surge's epicenter (p = 0.0024) through intensive human-to-human contact and maintained their dominance for 1.5 months until the Zero-COVID Policy was implemented. Multivariable regression found that the epidemic periods (p = 0.007) and epicenter (p = 0.001) were two significant factors associated with the dominant virus strains spread in the community. These dominant virus strains emerged at the outbreak's epicenter with frequent human-to-human contact and low vaccination coverage. The Level 3 Restrictions and Zero-COVID policy successfully controlled the outbreak in the community without city lockdowns. Our integrated method can identify the epidemiological conditions for emerging dominant virus with increasing epidemiological potential and support decision makers in rapidly containing outbreaks using public health measures that target fast-spreading virus strains.Taiwan's experience with severe acute respiratory syndrome coronavirus (SARS-CoV) in 2003 guided its development of strategies to defend against SARS-CoV-2 in 2020, which enabled the successful control of Coronavirus disease 2019 (COVID-19) cases from 2020 through March 2021. However, in late-April 2021, the imported Alpha variant began to cause COVID-19 outbreaks at an exceptional rate in Taiwan. In this study, we aimed to determine what epidemiological conditions enabled the SARS-CoV-2 Alpha variant strains to become dominant and decline later during a surge in the outbreak. In conjunction with contact-tracing investigations, we used our bioinformatics software, CoVConvert and IniCoV, to analyze whole-genome sequences of 101 Taiwan Alpha strains. Univariate and multivariable regression analyses revealed the epidemiological factors associated with viral dominance. Univariate analysis showed the dominant Alpha strains were preferentially selected in the surge's epicenter (p = 0.0024) through intensive human-to-human contact and maintained their dominance for 1.5 months until the Zero-COVID Policy was implemented. Multivariable regression found that the epidemic periods (p = 0.007) and epicenter (p = 0.001) were two significant factors associated with the dominant virus strains spread in the community. These dominant virus strains emerged at the outbreak's epicenter with frequent human-to-human contact and low vaccination coverage. The Level 3 Restrictions and Zero-COVID policy successfully controlled the outbreak in the community without city lockdowns. Our integrated method can identify the epidemiological conditions for emerging dominant virus with increasing epidemiological potential and support decision makers in rapidly containing outbreaks using public health measures that target fast-spreading virus strains.
Taiwan’s experience with severe acute respiratory syndrome coronavirus (SARS-CoV) in 2003 guided its development of strategies to defend against SARS-CoV-2 in 2020, which enabled the successful control of Coronavirus disease 2019 (COVID-19) cases from 2020 through March 2021. However, in late-April 2021, the imported Alpha variant began to cause COVID-19 outbreaks at an exceptional rate in Taiwan. In this study, we aimed to determine what epidemiological conditions enabled the SARS-CoV-2 Alpha variant strains to become dominant and decline later during a surge in the outbreak. In conjunction with contact-tracing investigations, we used our bioinformatics software, CoVConvert and IniCoV, to analyze whole-genome sequences of 101 Taiwan Alpha strains. Univariate and multivariable regression analyses revealed the epidemiological factors associated with viral dominance. Univariate analysis showed the dominant Alpha strains were preferentially selected in the surge’s epicenter (p = 0.0024) through intensive human-to-human contact and maintained their dominance for 1.5 months until the Zero-COVID Policy was implemented. Multivariable regression found that the epidemic periods (p = 0.007) and epicenter (p = 0.001) were two significant factors associated with the dominant virus strains spread in the community. These dominant virus strains emerged at the outbreak’s epicenter with frequent human-to-human contact and low vaccination coverage. The Level 3 Restrictions and Zero-COVID policy successfully controlled the outbreak in the community without city lockdowns. Our integrated method can identify the epidemiological conditions for emerging dominant virus with increasing epidemiological potential and support decision makers in rapidly containing outbreaks using public health measures that target fast-spreading virus strains. This figure summarizes our major findings in this study. Before the outbreak (T0, Pre-outbreak), the imported Alpha variant strains were heterogeneous with high viral genome divergence. However, such diversity significantly decreased during the T1 period (versus T0, p < 0.0001), when the dominant virus strains with selective advantages appeared. We also investigated the epidemiological conditions in Taiwan that facilitated the emergence of the predominant virus strain in the T1 period. The effective reproductive numbers over time (Rt) for the viruses from the imported cases were all zero at T0 period before the outbreak. However, the mean Rt values of the viruses from the pilots to quarantine hotel staff and subsequent dominant virus strains in the community (i.e. same sequence identities as the ID-3445/1263/1186) increased rapidly. Specific epidemiological conditions, including unmasked dining in many teahouses, and customers’ movement across teahouses, helped the dominant Alpha variant strains with a selective advantage. This study demonstrated that natural selection of a dominant virus strain (prior to immune selection) progressed in three stages: (1) selection started from a diverse virus pool (i.e. imported viruses at T0), (2) selection advantages increased through virus replication, in which the progeny virus had more advantages than its parent virus, and (3) selection of a fast-spreading virus strain through human-to-human transmission when a community had suitable epidemiological conditions (i.e. our T1 period and epicenter). Most importantly, COVID-19 cases dropped sharply alongside the two important population-intervention strategies (Level 3 Restrictions and Zero-COVID policy). [Display omitted] •Frequent human-to-human contact at the epicenter selected dominant SARS-CoV-2 strains.•Dominant SARS-CoV-2 strains had the highest Rt values under specific epidemiological conditions.•Level 3 Restrictions and Zero-COVID Policy were effective without lockdown.•Individual- and population-based prevention measures contained fast-spreading dominant virus strains.•Preventing cluster cases that would have aided viral selection effectively defended against VOCs.
Taiwan’s experience with severe acute respiratory syndrome coronavirus (SARS-CoV) in 2003 guided its development of strategies to defend against SARS-CoV-2 in 2020, which enabled the successful control of Coronavirus disease 2019 (COVID-19) cases from 2020 through March 2021. However, in late-April 2021, the imported Alpha variant began to cause COVID-19 outbreaks at an exceptional rate in Taiwan. In this study, we aimed to determine what epidemiological conditions enabled the SARS-CoV-2 Alpha variant strains to become dominant and decline later during a surge in the outbreak. In conjunction with contact-tracing investigations, we used our bioinformatics software, CoVConvert and IniCoV, to analyze whole-genome sequences of 101 Taiwan Alpha strains. Univariate and multivariable regression analyses revealed the epidemiological factors associated with viral dominance. Univariate analysis showed the dominant Alpha strains were preferentially selected in the surge’s epicenter (p = 0.0024) through intensive human-to-human contact and maintained their dominance for 1.5 months until the Zero-COVID Policy was implemented. Multivariable regression found that the epidemic periods (p = 0.007) and epicenter (p = 0.001) were two significant factors associated with the dominant virus strains spread in the community. These dominant virus strains emerged at the outbreak’s epicenter with frequent human-to-human contact and low vaccination coverage. The Level 3 Restrictions and Zero-COVID policy successfully controlled the outbreak in the community without city lockdowns. Our integrated method can identify the epidemiological conditions for emerging dominant virus with increasing epidemiological potential and support decision makers in rapidly containing outbreaks using public health measures that target fast-spreading virus strains.
ArticleNumber e22436
Author King, Chwan-Chuen
Tung, Tsung-Hua
Chan, Ta-Chien
Shang, Hung-Sheng
Fan, Yi-Chin
Huang, Chung-Guei
Kao, Chuan-Liang
Liu, Wei
Chang, Sui-Yuan
Hung, Kuo-Sheng
Lin, Wan-Yu
Yang, Chin-Rur
Tsai, Jih-Jin
Daisy Liu, Li-Yu
Wu, Hui-Lin
Ku, Chia-Chi
Gong, Yu-Nong
Author_xml – sequence: 1
  givenname: Chin-Rur
  orcidid: 0000-0002-0178-7744
  surname: Yang
  fullname: Yang, Chin-Rur
  organization: Graduate Institute of Immunology, College of Medicine, National Taiwan University, 1 Jen-Ai Road Section 1, Taipei, 10051, Taiwan, ROC
– sequence: 2
  givenname: Sui-Yuan
  orcidid: 0000-0002-6009-6724
  surname: Chang
  fullname: Chang, Sui-Yuan
  organization: Department (Dept.) of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, 10051, Taiwan, ROC
– sequence: 3
  givenname: Yu-Nong
  orcidid: 0000-0002-6799-1561
  surname: Gong
  fullname: Gong, Yu-Nong
  organization: Research Center for Emerging Viral Infections, College of Medicine, Chang Gung University, Taoyuan, 33302, Taiwan, ROC
– sequence: 4
  givenname: Chung-Guei
  orcidid: 0000-0002-0598-5684
  surname: Huang
  fullname: Huang, Chung-Guei
  organization: Dept. of Laboratory Medicine, Linkou Chang Gung Memorial Hospital, Taoyuan, 33302, Taiwan, ROC
– sequence: 5
  givenname: Tsung-Hua
  orcidid: 0000-0003-4867-5544
  surname: Tung
  fullname: Tung, Tsung-Hua
  organization: Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, NTU 17 Xu-Zhou Road, Taipei, 10055, Taiwan, ROC
– sequence: 6
  givenname: Wei
  orcidid: 0000-0003-2829-4226
  surname: Liu
  fullname: Liu, Wei
  organization: Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, NTU 17 Xu-Zhou Road, Taipei, 10055, Taiwan, ROC
– sequence: 7
  givenname: Ta-Chien
  orcidid: 0000-0002-1685-783X
  surname: Chan
  fullname: Chan, Ta-Chien
  organization: Research Center for Humanities and Social Sciences, Academia Sinica, Taipei, 11529, Taiwan, ROC
– sequence: 8
  givenname: Kuo-Sheng
  orcidid: 0000-0002-7643-9218
  surname: Hung
  fullname: Hung, Kuo-Sheng
  organization: Center for Precision Medicine and Genomics, Tri-Service General Hospital, National Defense Medical Center, Taipei, 11490, Taiwan, ROC
– sequence: 9
  givenname: Hung-Sheng
  surname: Shang
  fullname: Shang, Hung-Sheng
  organization: Division of Clinical Pathology, Dept. of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, 11490, Taiwan, ROC
– sequence: 10
  givenname: Jih-Jin
  orcidid: 0000-0003-2226-8916
  surname: Tsai
  fullname: Tsai, Jih-Jin
  organization: School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, 80708, Taiwan, ROC
– sequence: 11
  givenname: Chuan-Liang
  surname: Kao
  fullname: Kao, Chuan-Liang
  organization: Department (Dept.) of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, 10051, Taiwan, ROC
– sequence: 12
  givenname: Hui-Lin
  surname: Wu
  fullname: Wu, Hui-Lin
  organization: Hepatitis Research Center, National Taiwan University Hospital, Taipei, 10051, Taiwan, ROC
– sequence: 13
  givenname: Li-Yu
  surname: Daisy Liu
  fullname: Daisy Liu, Li-Yu
  organization: Division of Biometry, Department of Agronomy, National Taiwan University, Taipei, 10617, Taiwan, ROC
– sequence: 14
  givenname: Wan-Yu
  orcidid: 0000-0002-3385-4702
  surname: Lin
  fullname: Lin, Wan-Yu
  organization: Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, NTU 17 Xu-Zhou Road, Taipei, 10055, Taiwan, ROC
– sequence: 15
  givenname: Yi-Chin
  orcidid: 0000-0003-1866-0800
  surname: Fan
  fullname: Fan, Yi-Chin
  organization: Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, NTU 17 Xu-Zhou Road, Taipei, 10055, Taiwan, ROC
– sequence: 16
  givenname: Chwan-Chuen
  surname: King
  fullname: King, Chwan-Chuen
  email: chwanchuen@gmail.com
  organization: Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, NTU 17 Xu-Zhou Road, Taipei, 10055, Taiwan, ROC
– sequence: 17
  givenname: Chia-Chi
  orcidid: 0000-0002-5740-1505
  surname: Ku
  fullname: Ku, Chia-Chi
  email: chiachiku@ntu.edu.tw
  organization: Graduate Institute of Immunology, College of Medicine, National Taiwan University, 1 Jen-Ai Road Section 1, Taipei, 10051, Taiwan, ROC
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38107297$$D View this record in MEDLINE/PubMed
BookMark eNqFUstu1DAUjVARLaWfAPKSTQa_k4gFqkY8KlVCogNby3GuZzwk9mA7VN2x4h_4Pb6EpDNFiM2sfOV7zrlX95ynxYkPHoriOcELgol8tV1soHd3wS8opmwBlHImHxVnlGNR1pzjk3_q0-IipS3GmIhaNhV7UpyymuCKNtVZ8XO1AQQDxDV4A0j7DqXRGEjJjj2ahgzO6-yCR8Gim8tPN-UyfCkp6sLc8BmlHLXzCd26vEHOmwg6Ob9GsHMdDM6gXcjgs9P91EUr7W61__3jV0LT5gSFMbcT4-uz4rHVfYKLw3tefH73drX8UF5_fH-1vLwujSAkl6JpRCU4EzURbYeNtphXpOKk4VYyI6AVuiGsq7qGYms7zAVtJRUtFoZY2bLz4mqv2wW9VbvoBh3vVNBO3X-EuFY6Zmd6UIIw1jCLLROSN9romkssiWatlaKlbNJ6udfaxfBthJTV4JKBvtcewpgUI4JVNZkcOAqlDWaMColn1RcH6NgO0P3d8cGyCfB6DzAxpBTBKuPyvUWzE70iWM0ZUVt1yIiaM6L2GZnY4j_2w4BjvDd7HkzufHcQVTJujkznIpg8nc8dUfgDi2TYcA
CitedBy_id crossref_primary_10_1016_j_bj_2024_100820
Cites_doi 10.1126/science.abj4336
10.1001/jamainternmed.2021.1644
10.1128/JCM.00741-21
10.3390/v15051194
10.1016/j.epidem.2023.100677
10.1016/j.jmgm.2022.108193
10.1186/s13578-022-00770-1
10.1016/S1473-3099(20)30120-1
10.1126/science.abm1208
10.3201/eid2801.211804
10.1126/science.abq6109
10.1007/s10654-023-00963-z
10.3201/eid2810.220456
10.1016/j.ijid.2009.06.006
10.1038/s41588-022-01033-y
10.1371/journal.pone.0031162
10.3201/eid2806.211821
10.1016/j.ijid.2021.06.002
10.1371/journal.pntd.0009312
10.1186/s12859-020-03650-y
10.1128/mBio.00587-21
10.1371/journal.pntd.0009835
10.1186/s13073-022-01098-8
10.1080/22221751.2020.1782271
10.1186/s12859-021-04017-7
10.1038/s41598-022-16011-x
10.1093/molbev/msg182
10.1038/s41467-023-38435-3
10.2147/IDR.S328327
10.1186/s13059-014-0538-4
10.1002/jmv.28366
10.1016/S2666-5247(21)00121-X
10.1016/j.celrep.2021.110205
10.1136/bmj.o859
10.1371/journal.pntd.0006827
10.1038/s41591-022-01836-w
10.3201/eid2904.221497
10.1186/s12985-022-01896-x
ContentType Journal Article
Copyright 2023 The Author(s)
2023 The Author(s).
Copyright_xml – notice: 2023 The Author(s)
– notice: 2023 The Author(s).
DBID 6I.
AAFTH
AAYXX
CITATION
NPM
7X8
7S9
L.6
DOA
DOI 10.1016/j.heliyon.2023.e22436
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList
PubMed
MEDLINE - Academic

AGRICOLA
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
EISSN 2405-8440
ExternalDocumentID oai_doaj_org_article_513393f0f35649aca846061a3bf65b23
38107297
10_1016_j_heliyon_2023_e22436
S2405844023096445
Genre Journal Article
GeographicLocations Taiwan
GeographicLocations_xml – name: Taiwan
GroupedDBID 0R~
457
53G
5VS
6I.
AAEDW
AAFTH
AAFWJ
AALRI
AAYWO
ABMAC
ACGFS
ACLIJ
ACVFH
ADBBV
ADCNI
ADEZE
ADVLN
AEUPX
AEXQZ
AFJKZ
AFPKN
AFPUW
AFTJW
AGHFR
AIGII
AITUG
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOIJS
APXCP
BAWUL
BCNDV
DIK
EBS
EJD
FDB
GROUPED_DOAJ
HYE
IPNFZ
KQ8
M~E
O9-
OK1
RIG
ROL
RPM
SSZ
AAYXX
CITATION
AACTN
NPM
7X8
7S9
L.6
ID FETCH-LOGICAL-c511t-599575435815bd0caf047174194f63c5eb5a913d7d920ffd0452b625b05c1f6b3
IEDL.DBID DOA
ISSN 2405-8440
IngestDate Wed Aug 27 01:22:24 EDT 2025
Fri Aug 22 21:00:39 EDT 2025
Fri Jul 11 01:45:07 EDT 2025
Thu Apr 03 07:01:58 EDT 2025
Sun Jul 06 05:05:31 EDT 2025
Thu Apr 24 22:58:05 EDT 2025
Sat Aug 09 17:31:56 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords SARS-CoV-2
Viral variants
Whole-genome sequencing
Epicenter
Transmission
Taiwan
Spatio-temporal analysis
Community outbreak
Reproduction number
Bioinformatics
Language English
License This is an open access article under the CC BY license.
2023 The Author(s).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c511t-599575435815bd0caf047174194f63c5eb5a913d7d920ffd0452b625b05c1f6b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-6009-6724
0000-0002-7643-9218
0000-0002-3385-4702
0000-0003-2829-4226
0000-0002-1685-783X
0000-0002-6799-1561
0000-0003-4867-5544
0000-0003-2226-8916
0000-0002-5740-1505
0000-0002-0178-7744
0000-0003-1866-0800
0000-0002-0598-5684
OpenAccessLink https://doaj.org/article/513393f0f35649aca846061a3bf65b23
PMID 38107297
PQID 2903325603
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_513393f0f35649aca846061a3bf65b23
proquest_miscellaneous_3153781440
proquest_miscellaneous_2903325603
pubmed_primary_38107297
crossref_citationtrail_10_1016_j_heliyon_2023_e22436
crossref_primary_10_1016_j_heliyon_2023_e22436
elsevier_sciencedirect_doi_10_1016_j_heliyon_2023_e22436
PublicationCentury 2000
PublicationDate December 2023
2023-12-00
2023-Dec
20231201
2023-12-01
PublicationDateYYYYMMDD 2023-12-01
PublicationDate_xml – month: 12
  year: 2023
  text: December 2023
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Heliyon
PublicationTitleAlternate Heliyon
PublicationYear 2023
Publisher Elsevier Ltd
Elsevier
Publisher_xml – name: Elsevier Ltd
– name: Elsevier
References Mannsverk (bib34) 2022; 19
Chan (bib9) 2022; 12
Tamura (bib38) 2023; 14
Verghese (bib28) 2021; 59
Shao (bib46) 2023; 29
Gruca (bib35) 2021; 22
Lin (bib10) 2022; 38
Gu (bib19) 2022; 28
Hsueh, Yang (bib1) 2005; 38
Berec (bib40) 2023; 43
Li (bib31) 2022; 38
Wilkinson (bib20) 2021; 374
Robishaw (bib7) 2021; 2
Tonkin-Hill (bib32) 2021
Subramoney (bib45) 2023; 15
Dong, Du, Gardner (bib3) 2020; 20
Wen (bib24) 2010; 14
Ku (bib8) 2022
Lamarca (bib6) 2021; 15
Dyer (bib16) 2022; 376
Sutton (bib22) 2022; 28
Yen (bib2) 2021; 110
Grimaldi (bib43) 2022; 14
Pozo-Martin (bib39) 2023; 38
Normile (bib17) 2022; 376
Chen (bib18) 2022; 54
Cheng (bib29) 2021; 12
Bennett (bib25) 2003; 20
Jian (bib26) 2021; 14
Grad, Lipsitch (bib42) 2014; 15
Fung (bib37) 2022; 12
Pitsillou (bib36) 2022; 114
Akhmetzhanov (bib15) 2022; 28
Subissi (bib30) 2022; 28
Tai (bib13) 2022
Ng (bib33) 2021; 181
Gong (bib21) 2020; 9
Wolf (bib44) 2023; 95
Kao (bib23) 2012; 7
Yang (bib11) 2020; 21
Davies (bib5) 2021
Obermeyer (bib4) 2022; 376
Pan (bib27) 2021; 15
Liu (bib12) 2021
Liu (bib14) 2022; 9
Ko (bib41) 2018; 12
Jian (10.1016/j.heliyon.2023.e22436_bib26) 2021; 14
Wolf (10.1016/j.heliyon.2023.e22436_bib44) 2023; 95
Obermeyer (10.1016/j.heliyon.2023.e22436_bib4) 2022; 376
Lin (10.1016/j.heliyon.2023.e22436_bib10) 2022; 38
Dong (10.1016/j.heliyon.2023.e22436_bib3) 2020; 20
Ng (10.1016/j.heliyon.2023.e22436_bib33) 2021; 181
Gruca (10.1016/j.heliyon.2023.e22436_bib35) 2021; 22
Wen (10.1016/j.heliyon.2023.e22436_bib24) 2010; 14
Grimaldi (10.1016/j.heliyon.2023.e22436_bib43) 2022; 14
Tonkin-Hill (10.1016/j.heliyon.2023.e22436_bib32) 2021
Ku (10.1016/j.heliyon.2023.e22436_bib8) 2022
Li (10.1016/j.heliyon.2023.e22436_bib31) 2022; 38
Wilkinson (10.1016/j.heliyon.2023.e22436_bib20) 2021; 374
Subissi (10.1016/j.heliyon.2023.e22436_bib30) 2022; 28
Kao (10.1016/j.heliyon.2023.e22436_bib23) 2012; 7
Chan (10.1016/j.heliyon.2023.e22436_bib9) 2022; 12
Shao (10.1016/j.heliyon.2023.e22436_bib46) 2023; 29
Akhmetzhanov (10.1016/j.heliyon.2023.e22436_bib15) 2022; 28
Grad (10.1016/j.heliyon.2023.e22436_bib42) 2014; 15
Cheng (10.1016/j.heliyon.2023.e22436_bib29) 2021; 12
Ko (10.1016/j.heliyon.2023.e22436_bib41) 2018; 12
Pozo-Martin (10.1016/j.heliyon.2023.e22436_bib39) 2023; 38
Berec (10.1016/j.heliyon.2023.e22436_bib40) 2023; 43
Yen (10.1016/j.heliyon.2023.e22436_bib2) 2021; 110
Liu (10.1016/j.heliyon.2023.e22436_bib14) 2022; 9
Fung (10.1016/j.heliyon.2023.e22436_bib37) 2022; 12
Lamarca (10.1016/j.heliyon.2023.e22436_bib6) 2021; 15
Normile (10.1016/j.heliyon.2023.e22436_bib17) 2022; 376
Gong (10.1016/j.heliyon.2023.e22436_bib21) 2020; 9
Hsueh (10.1016/j.heliyon.2023.e22436_bib1) 2005; 38
Tamura (10.1016/j.heliyon.2023.e22436_bib38) 2023; 14
Liu (10.1016/j.heliyon.2023.e22436_bib12) 2021
Dyer (10.1016/j.heliyon.2023.e22436_bib16) 2022; 376
Pitsillou (10.1016/j.heliyon.2023.e22436_bib36) 2022; 114
Yang (10.1016/j.heliyon.2023.e22436_bib11) 2020; 21
Bennett (10.1016/j.heliyon.2023.e22436_bib25) 2003; 20
Davies (10.1016/j.heliyon.2023.e22436_bib5) 2021
Gu (10.1016/j.heliyon.2023.e22436_bib19) 2022; 28
Mannsverk (10.1016/j.heliyon.2023.e22436_bib34) 2022; 19
Verghese (10.1016/j.heliyon.2023.e22436_bib28) 2021; 59
Sutton (10.1016/j.heliyon.2023.e22436_bib22) 2022; 28
Chen (10.1016/j.heliyon.2023.e22436_bib18) 2022; 54
Robishaw (10.1016/j.heliyon.2023.e22436_bib7) 2021; 2
Tai (10.1016/j.heliyon.2023.e22436_bib13) 2022
Pan (10.1016/j.heliyon.2023.e22436_bib27) 2021; 15
Subramoney (10.1016/j.heliyon.2023.e22436_bib45) 2023; 15
References_xml – volume: 110
  start-page: 469
  year: 2021
  end-page: 478
  ident: bib2
  article-title: Learning from the past: Taiwan's responses to COVID-19 versus SARS
  publication-title: Int. J. Infect. Dis.
– volume: 38
  start-page: 243
  year: 2023
  end-page: 266
  ident: bib39
  article-title: Comparative effectiveness of contact tracing interventions in the context of the COVID-19 pandemic: a systematic review
  publication-title: Eur. J. Epidemiol.
– year: 2021
  ident: bib12
  article-title: Taiwan CDC MOHW110-CDC-C-315-124116 Report: Pathogen Analysis of Pneumonic Encephalitis and Unexplained Infectious Diseases
– volume: 14
  start-page: 90
  year: 2022
  ident: bib43
  article-title: Improved SARS-CoV-2 sequencing surveillance allows the identification of new variants and signatures in infected patients
  publication-title: Genome Med.
– volume: 9
  year: 2022
  ident: bib14
  article-title: Identification and analysis of SARS-CoV-2 alpha variants in the largest Taiwan COVID-19 outbreak in 2021
  publication-title: Front. Med. (Lausanne)
– volume: 114
  year: 2022
  ident: bib36
  article-title: The SARS-CoV-2 helicase as a target for antiviral therapy: identification of potential small molecule inhibitors by in silico modelling
  publication-title: J. Mol. Graph. Model.
– volume: 54
  start-page: 499
  year: 2022
  end-page: 507
  ident: bib18
  article-title: Global landscape of SARS-CoV-2 genomic surveillance and data sharing
  publication-title: Nat. Genet.
– volume: 28
  start-page: 247
  year: 2022
  end-page: 250
  ident: bib19
  article-title: Monitoring international travelers arriving in Hong Kong for genomic surveillance of SARS-CoV-2
  publication-title: Emerg. Infect. Dis.
– volume: 28
  start-page: 1101
  year: 2022
  end-page: 1109
  ident: bib22
  article-title: Detection of SARS-CoV-2 B.1.351 (Beta) variant through wastewater surveillance before case detection in a community, Oregon, USA
  publication-title: Emerg. Infect. Dis.
– volume: 14
  start-page: 2800
  year: 2023
  ident: bib38
  article-title: Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants
  publication-title: Nat. Commun.
– volume: 20
  start-page: 533
  year: 2020
  end-page: 534
  ident: bib3
  article-title: An interactive web-based dashboard to track COVID-19 in real time
  publication-title: Lancet Infect. Dis.
– year: 2022
  ident: bib8
  article-title: Record of Resilience: Documenting Taipei's Pandemic Response
– volume: 20
  start-page: 1650
  year: 2003
  end-page: 1658
  ident: bib25
  article-title: Selection-driven evolution of emergent dengue virus
  publication-title: Mol. Biol. Evol.
– volume: 21
  start-page: 316
  year: 2020
  ident: bib11
  article-title: FluConvert and IniFlu: a suite of integrated software to identify novel signatures of emerging influenza viruses with increasing risk
  publication-title: BMC Bioinf.
– year: 2022
  ident: bib13
  article-title: Spatial and Temporal Origin of the Third SARS-COV-2 Outbreak in Taiwan
– volume: 15
  year: 2023
  ident: bib45
  article-title: Molecular epidemiology of SARS-CoV-2 during five COVID-19 waves and the significance of low-frequency lineages
  publication-title: Viruses
– volume: 376
  start-page: 1327
  year: 2022
  end-page: 1332
  ident: bib4
  article-title: Analysis of 6.4 million SARS-CoV-2 genomes identifies mutations associated with fitness
  publication-title: Science
– volume: 15
  year: 2021
  ident: bib27
  article-title: Use of seroprevalence to guide dengue vaccination plans for older adults in a dengue non-endemic country
  publication-title: PLoS Neglected Trop. Dis.
– volume: 28
  start-page: 1110
  year: 2022
  end-page: 1115
  ident: bib30
  article-title: An early warning system for emerging SARS-CoV-2 variants
  publication-title: Nat. Med.
– volume: 2
  start-page: e481
  year: 2021
  end-page: e484
  ident: bib7
  article-title: Genomic surveillance to combat COVID-19: challenges and opportunities
  publication-title: Lancet Microbe
– volume: 15
  year: 2021
  ident: bib6
  article-title: Genomic surveillance of SARS-CoV-2 tracks early interstate transmission of P.1 lineage and diversification within P.2 clade in Brazil
  publication-title: PLoS Neglected Trop. Dis.
– start-page: 10
  year: 2021
  ident: bib32
  article-title: Patterns of within-host genetic diversity in SARS-CoV-2
  publication-title: Elife
– volume: 376
  start-page: o859
  year: 2022
  ident: bib16
  article-title: Covid-19: lockdowns spread in China as omicron tests "zero covid" strategy
  publication-title: BMJ
– volume: 12
  year: 2021
  ident: bib29
  article-title: D614G substitution of SARS-CoV-2 spike protein increases syncytium formation and virus titer via enhanced furin-mediated spike Cleavage
  publication-title: mBio
– volume: 12
  year: 2018
  ident: bib41
  article-title: Inter- and intra-host sequence diversity reveal the emergence of viral variants during an overwintering epidemic caused by dengue virus serotype 2 in southern Taiwan
  publication-title: PLoS Neglected Trop. Dis.
– volume: 38
  year: 2022
  ident: bib31
  article-title: Two-step fitness selection for intra-host variations in SARS-CoV-2
  publication-title: Cell Rep.
– volume: 28
  start-page: 2051
  year: 2022
  end-page: 2059
  ident: bib15
  article-title: Transmission dynamics and effectiveness of control measures during COVID-19 surge, Taiwan, April-August 2021
  publication-title: Emerg. Infect. Dis.
– volume: 376
  start-page: 333
  year: 2022
  end-page: 334
  ident: bib17
  article-title: China refuses to end harsh lockdowns
  publication-title: Science
– volume: 9
  start-page: 1457
  year: 2020
  end-page: 1466
  ident: bib21
  article-title: SARS-CoV-2 genomic surveillance in Taiwan revealed novel ORF8-deletion mutant and clade possibly associated with infections in Middle East
  publication-title: Emerg. Microb. Infect.
– volume: 95
  year: 2023
  ident: bib44
  article-title: Molecular evolution of SARS-CoV-2 from december 2019 to August 2022
  publication-title: J. Med. Virol.
– volume: 12
  year: 2022
  ident: bib9
  article-title: Effectiveness of controlling COVID-19 epidemic by implementing soft lockdown policy and extensive community screening in Taiwan
  publication-title: Sci. Rep.
– volume: 38
  start-page: 208
  year: 2022
  end-page: 214
  ident: bib10
  article-title: Investigation of the COVID-19 Cluster events at an agricultural products marketing company in Northern Taiwan in 2021
  publication-title: Taiwan Epidemiol. Bull.
– start-page: 372
  year: 2021
  ident: bib5
  article-title: Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
  publication-title: Science
– volume: 12
  start-page: 36
  year: 2022
  ident: bib37
  article-title: SARS-CoV-2 NSP13 helicase suppresses interferon signaling by perturbing JAK1 phosphorylation of STAT1
  publication-title: Cell Biosci.
– volume: 14
  start-page: e334
  year: 2010
  end-page: e343
  ident: bib24
  article-title: Spatial-temporal patterns of dengue in areas at risk of dengue hemorrhagic fever in Kaohsiung, Taiwan, 2002
  publication-title: Int. J. Infect. Dis.
– volume: 29
  start-page: 792
  year: 2023
  end-page: 796
  ident: bib46
  article-title: Emergence and persistent dominance of SARS-CoV-2 omicron BA.2.3.7 variant, Taiwan
  publication-title: Emerg. Infect. Dis.
– volume: 59
  year: 2021
  ident: bib28
  article-title: A SARS-CoV-2 variant with L452R and E484Q neutralization resistance mutations
  publication-title: J. Clin. Microbiol.
– volume: 7
  year: 2012
  ident: bib23
  article-title: Emerged HA and NA mutants of the pandemic influenza H1N1 viruses with increasing epidemiological significance in Taipei and Kaohsiung, Taiwan, 2009-10
  publication-title: PLoS One
– volume: 38
  start-page: 82
  year: 2005
  end-page: 88
  ident: bib1
  article-title: Severe acute respiratory syndrome epidemic in Taiwan, 2003
  publication-title: J. Microbiol. Immunol. Infect.
– volume: 374
  start-page: 423
  year: 2021
  end-page: 431
  ident: bib20
  article-title: A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa
  publication-title: Science
– volume: 43
  year: 2023
  ident: bib40
  article-title: On the contact tracing for COVID-19: a simulation study
  publication-title: Epidemics
– volume: 181
  start-page: 913
  year: 2021
  end-page: 921
  ident: bib33
  article-title: Comparison of estimated effectiveness of case-based and population-based interventions on COVID-19 containment in Taiwan
  publication-title: JAMA Intern. Med.
– volume: 22
  start-page: 182
  year: 2021
  ident: bib35
  article-title: Common low complexity regions for SARS-CoV-2 and human proteomes as potential multidirectional risk factor in vaccine development
  publication-title: BMC Bioinf.
– volume: 19
  start-page: 164
  year: 2022
  ident: bib34
  article-title: SARS-CoV-2 variants of concern and spike protein mutational dynamics in a Swedish cohort during 2021, studied by Nanopore sequencing
  publication-title: Virol. J.
– volume: 15
  start-page: 538
  year: 2014
  ident: bib42
  article-title: Epidemiologic data and pathogen genome sequences: a powerful synergy for public health
  publication-title: Genome Biol.
– volume: 14
  start-page: 3255
  year: 2021
  end-page: 3261
  ident: bib26
  article-title: Clinical comparison of three sample-to-answer systems for detecting SARS-CoV-2 in B.1.1.7 lineage emergence
  publication-title: Infect. Drug Resist.
– year: 2021
  ident: 10.1016/j.heliyon.2023.e22436_bib12
– volume: 374
  start-page: 423
  issue: 6566
  year: 2021
  ident: 10.1016/j.heliyon.2023.e22436_bib20
  article-title: A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa
  publication-title: Science
  doi: 10.1126/science.abj4336
– volume: 181
  start-page: 913
  issue: 7
  year: 2021
  ident: 10.1016/j.heliyon.2023.e22436_bib33
  article-title: Comparison of estimated effectiveness of case-based and population-based interventions on COVID-19 containment in Taiwan
  publication-title: JAMA Intern. Med.
  doi: 10.1001/jamainternmed.2021.1644
– volume: 59
  issue: 7
  year: 2021
  ident: 10.1016/j.heliyon.2023.e22436_bib28
  article-title: A SARS-CoV-2 variant with L452R and E484Q neutralization resistance mutations
  publication-title: J. Clin. Microbiol.
  doi: 10.1128/JCM.00741-21
– volume: 15
  issue: 5
  year: 2023
  ident: 10.1016/j.heliyon.2023.e22436_bib45
  article-title: Molecular epidemiology of SARS-CoV-2 during five COVID-19 waves and the significance of low-frequency lineages
  publication-title: Viruses
  doi: 10.3390/v15051194
– start-page: 10
  year: 2021
  ident: 10.1016/j.heliyon.2023.e22436_bib32
  article-title: Patterns of within-host genetic diversity in SARS-CoV-2
  publication-title: Elife
– volume: 43
  year: 2023
  ident: 10.1016/j.heliyon.2023.e22436_bib40
  article-title: On the contact tracing for COVID-19: a simulation study
  publication-title: Epidemics
  doi: 10.1016/j.epidem.2023.100677
– year: 2022
  ident: 10.1016/j.heliyon.2023.e22436_bib8
– year: 2022
  ident: 10.1016/j.heliyon.2023.e22436_bib13
– volume: 114
  year: 2022
  ident: 10.1016/j.heliyon.2023.e22436_bib36
  article-title: The SARS-CoV-2 helicase as a target for antiviral therapy: identification of potential small molecule inhibitors by in silico modelling
  publication-title: J. Mol. Graph. Model.
  doi: 10.1016/j.jmgm.2022.108193
– volume: 12
  start-page: 36
  issue: 1
  year: 2022
  ident: 10.1016/j.heliyon.2023.e22436_bib37
  article-title: SARS-CoV-2 NSP13 helicase suppresses interferon signaling by perturbing JAK1 phosphorylation of STAT1
  publication-title: Cell Biosci.
  doi: 10.1186/s13578-022-00770-1
– volume: 20
  start-page: 533
  issue: 5
  year: 2020
  ident: 10.1016/j.heliyon.2023.e22436_bib3
  article-title: An interactive web-based dashboard to track COVID-19 in real time
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(20)30120-1
– volume: 376
  start-page: 1327
  issue: 6599
  year: 2022
  ident: 10.1016/j.heliyon.2023.e22436_bib4
  article-title: Analysis of 6.4 million SARS-CoV-2 genomes identifies mutations associated with fitness
  publication-title: Science
  doi: 10.1126/science.abm1208
– volume: 28
  start-page: 247
  issue: 1
  year: 2022
  ident: 10.1016/j.heliyon.2023.e22436_bib19
  article-title: Monitoring international travelers arriving in Hong Kong for genomic surveillance of SARS-CoV-2
  publication-title: Emerg. Infect. Dis.
  doi: 10.3201/eid2801.211804
– volume: 376
  start-page: 333
  issue: 6591
  year: 2022
  ident: 10.1016/j.heliyon.2023.e22436_bib17
  article-title: China refuses to end harsh lockdowns
  publication-title: Science
  doi: 10.1126/science.abq6109
– volume: 38
  start-page: 243
  issue: 3
  year: 2023
  ident: 10.1016/j.heliyon.2023.e22436_bib39
  article-title: Comparative effectiveness of contact tracing interventions in the context of the COVID-19 pandemic: a systematic review
  publication-title: Eur. J. Epidemiol.
  doi: 10.1007/s10654-023-00963-z
– volume: 28
  start-page: 2051
  issue: 10
  year: 2022
  ident: 10.1016/j.heliyon.2023.e22436_bib15
  article-title: Transmission dynamics and effectiveness of control measures during COVID-19 surge, Taiwan, April-August 2021
  publication-title: Emerg. Infect. Dis.
  doi: 10.3201/eid2810.220456
– volume: 14
  start-page: e334
  issue: 4
  year: 2010
  ident: 10.1016/j.heliyon.2023.e22436_bib24
  article-title: Spatial-temporal patterns of dengue in areas at risk of dengue hemorrhagic fever in Kaohsiung, Taiwan, 2002
  publication-title: Int. J. Infect. Dis.
  doi: 10.1016/j.ijid.2009.06.006
– volume: 38
  start-page: 82
  issue: 2
  year: 2005
  ident: 10.1016/j.heliyon.2023.e22436_bib1
  article-title: Severe acute respiratory syndrome epidemic in Taiwan, 2003
  publication-title: J. Microbiol. Immunol. Infect.
– volume: 54
  start-page: 499
  issue: 4
  year: 2022
  ident: 10.1016/j.heliyon.2023.e22436_bib18
  article-title: Global landscape of SARS-CoV-2 genomic surveillance and data sharing
  publication-title: Nat. Genet.
  doi: 10.1038/s41588-022-01033-y
– volume: 7
  issue: 2
  year: 2012
  ident: 10.1016/j.heliyon.2023.e22436_bib23
  article-title: Emerged HA and NA mutants of the pandemic influenza H1N1 viruses with increasing epidemiological significance in Taipei and Kaohsiung, Taiwan, 2009-10
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0031162
– volume: 28
  start-page: 1101
  issue: 6
  year: 2022
  ident: 10.1016/j.heliyon.2023.e22436_bib22
  article-title: Detection of SARS-CoV-2 B.1.351 (Beta) variant through wastewater surveillance before case detection in a community, Oregon, USA
  publication-title: Emerg. Infect. Dis.
  doi: 10.3201/eid2806.211821
– volume: 110
  start-page: 469
  year: 2021
  ident: 10.1016/j.heliyon.2023.e22436_bib2
  article-title: Learning from the past: Taiwan's responses to COVID-19 versus SARS
  publication-title: Int. J. Infect. Dis.
  doi: 10.1016/j.ijid.2021.06.002
– volume: 15
  issue: 4
  year: 2021
  ident: 10.1016/j.heliyon.2023.e22436_bib27
  article-title: Use of seroprevalence to guide dengue vaccination plans for older adults in a dengue non-endemic country
  publication-title: PLoS Neglected Trop. Dis.
  doi: 10.1371/journal.pntd.0009312
– volume: 21
  start-page: 316
  issue: 1
  year: 2020
  ident: 10.1016/j.heliyon.2023.e22436_bib11
  article-title: FluConvert and IniFlu: a suite of integrated software to identify novel signatures of emerging influenza viruses with increasing risk
  publication-title: BMC Bioinf.
  doi: 10.1186/s12859-020-03650-y
– volume: 12
  issue: 4
  year: 2021
  ident: 10.1016/j.heliyon.2023.e22436_bib29
  article-title: D614G substitution of SARS-CoV-2 spike protein increases syncytium formation and virus titer via enhanced furin-mediated spike Cleavage
  publication-title: mBio
  doi: 10.1128/mBio.00587-21
– volume: 15
  issue: 10
  year: 2021
  ident: 10.1016/j.heliyon.2023.e22436_bib6
  article-title: Genomic surveillance of SARS-CoV-2 tracks early interstate transmission of P.1 lineage and diversification within P.2 clade in Brazil
  publication-title: PLoS Neglected Trop. Dis.
  doi: 10.1371/journal.pntd.0009835
– volume: 14
  start-page: 90
  issue: 1
  year: 2022
  ident: 10.1016/j.heliyon.2023.e22436_bib43
  article-title: Improved SARS-CoV-2 sequencing surveillance allows the identification of new variants and signatures in infected patients
  publication-title: Genome Med.
  doi: 10.1186/s13073-022-01098-8
– volume: 9
  start-page: 1457
  issue: 1
  year: 2020
  ident: 10.1016/j.heliyon.2023.e22436_bib21
  article-title: SARS-CoV-2 genomic surveillance in Taiwan revealed novel ORF8-deletion mutant and clade possibly associated with infections in Middle East
  publication-title: Emerg. Microb. Infect.
  doi: 10.1080/22221751.2020.1782271
– volume: 22
  start-page: 182
  issue: 1
  year: 2021
  ident: 10.1016/j.heliyon.2023.e22436_bib35
  article-title: Common low complexity regions for SARS-CoV-2 and human proteomes as potential multidirectional risk factor in vaccine development
  publication-title: BMC Bioinf.
  doi: 10.1186/s12859-021-04017-7
– volume: 12
  issue: 1
  year: 2022
  ident: 10.1016/j.heliyon.2023.e22436_bib9
  article-title: Effectiveness of controlling COVID-19 epidemic by implementing soft lockdown policy and extensive community screening in Taiwan
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-022-16011-x
– volume: 20
  start-page: 1650
  issue: 10
  year: 2003
  ident: 10.1016/j.heliyon.2023.e22436_bib25
  article-title: Selection-driven evolution of emergent dengue virus
  publication-title: Mol. Biol. Evol.
  doi: 10.1093/molbev/msg182
– volume: 14
  start-page: 2800
  issue: 1
  year: 2023
  ident: 10.1016/j.heliyon.2023.e22436_bib38
  article-title: Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-023-38435-3
– volume: 38
  start-page: 208
  issue: 16
  year: 2022
  ident: 10.1016/j.heliyon.2023.e22436_bib10
  article-title: Investigation of the COVID-19 Cluster events at an agricultural products marketing company in Northern Taiwan in 2021
  publication-title: Taiwan Epidemiol. Bull.
– volume: 14
  start-page: 3255
  year: 2021
  ident: 10.1016/j.heliyon.2023.e22436_bib26
  article-title: Clinical comparison of three sample-to-answer systems for detecting SARS-CoV-2 in B.1.1.7 lineage emergence
  publication-title: Infect. Drug Resist.
  doi: 10.2147/IDR.S328327
– volume: 15
  start-page: 538
  issue: 11
  year: 2014
  ident: 10.1016/j.heliyon.2023.e22436_bib42
  article-title: Epidemiologic data and pathogen genome sequences: a powerful synergy for public health
  publication-title: Genome Biol.
  doi: 10.1186/s13059-014-0538-4
– volume: 95
  issue: 1
  year: 2023
  ident: 10.1016/j.heliyon.2023.e22436_bib44
  article-title: Molecular evolution of SARS-CoV-2 from december 2019 to August 2022
  publication-title: J. Med. Virol.
  doi: 10.1002/jmv.28366
– start-page: 372
  issue: 6538
  year: 2021
  ident: 10.1016/j.heliyon.2023.e22436_bib5
  article-title: Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
  publication-title: Science
– volume: 9
  year: 2022
  ident: 10.1016/j.heliyon.2023.e22436_bib14
  article-title: Identification and analysis of SARS-CoV-2 alpha variants in the largest Taiwan COVID-19 outbreak in 2021
  publication-title: Front. Med. (Lausanne)
– volume: 2
  start-page: e481
  issue: 9
  year: 2021
  ident: 10.1016/j.heliyon.2023.e22436_bib7
  article-title: Genomic surveillance to combat COVID-19: challenges and opportunities
  publication-title: Lancet Microbe
  doi: 10.1016/S2666-5247(21)00121-X
– volume: 38
  issue: 2
  year: 2022
  ident: 10.1016/j.heliyon.2023.e22436_bib31
  article-title: Two-step fitness selection for intra-host variations in SARS-CoV-2
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2021.110205
– volume: 376
  start-page: o859
  year: 2022
  ident: 10.1016/j.heliyon.2023.e22436_bib16
  article-title: Covid-19: lockdowns spread in China as omicron tests "zero covid" strategy
  publication-title: BMJ
  doi: 10.1136/bmj.o859
– volume: 12
  issue: 10
  year: 2018
  ident: 10.1016/j.heliyon.2023.e22436_bib41
  article-title: Inter- and intra-host sequence diversity reveal the emergence of viral variants during an overwintering epidemic caused by dengue virus serotype 2 in southern Taiwan
  publication-title: PLoS Neglected Trop. Dis.
  doi: 10.1371/journal.pntd.0006827
– volume: 28
  start-page: 1110
  issue: 6
  year: 2022
  ident: 10.1016/j.heliyon.2023.e22436_bib30
  article-title: An early warning system for emerging SARS-CoV-2 variants
  publication-title: Nat. Med.
  doi: 10.1038/s41591-022-01836-w
– volume: 29
  start-page: 792
  issue: 4
  year: 2023
  ident: 10.1016/j.heliyon.2023.e22436_bib46
  article-title: Emergence and persistent dominance of SARS-CoV-2 omicron BA.2.3.7 variant, Taiwan
  publication-title: Emerg. Infect. Dis.
  doi: 10.3201/eid2904.221497
– volume: 19
  start-page: 164
  issue: 1
  year: 2022
  ident: 10.1016/j.heliyon.2023.e22436_bib34
  article-title: SARS-CoV-2 variants of concern and spike protein mutational dynamics in a Swedish cohort during 2021, studied by Nanopore sequencing
  publication-title: Virol. J.
  doi: 10.1186/s12985-022-01896-x
SSID ssj0001586973
Score 2.247177
Snippet Taiwan’s experience with severe acute respiratory syndrome coronavirus (SARS-CoV) in 2003 guided its development of strategies to defend against SARS-CoV-2 in...
Taiwan's experience with severe acute respiratory syndrome coronavirus (SARS-CoV) in 2003 guided its development of strategies to defend against SARS-CoV-2 in...
SourceID doaj
proquest
pubmed
crossref
elsevier
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e22436
SubjectTerms Bioinformatics
Community outbreak
computer software
COVID-19 infection
decline
Epicenter
issues and policy
public health
Reproduction number
SARS-CoV-2
Severe acute respiratory syndrome coronavirus
Severe acute respiratory syndrome coronavirus 2
Spatio-temporal analysis
Taiwan
Transmission
vaccination
Viral variants
viruses
Whole-genome sequencing
Title The emergence and successful elimination of SARS-CoV-2 dominant strains with increasing epidemic potential in Taiwan’s 2021 outbreak
URI https://dx.doi.org/10.1016/j.heliyon.2023.e22436
https://www.ncbi.nlm.nih.gov/pubmed/38107297
https://www.proquest.com/docview/2903325603
https://www.proquest.com/docview/3153781440
https://doaj.org/article/513393f0f35649aca846061a3bf65b23
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQKyEuiPJcCpWRuHqbjR9JjkvVqqIqhz6gN8tObJF2lVQkEeqNE_-Bv8cv6Yyd3ZZDtReukZPYnrG-z_bMN4R8FHmRyaziLBfCMwGMgxXOJCzzCth2CggYMryPv6jDc_H5Ql7cK_WFMWFRHjhO3C7WHym4TzyXShSmNACYgEGGW6-kTYPOJ2Devc1UzA_OVZHxu5Sd3cvpd7eob1rUPE351AF0BVnmOzAKmv3_YNJDnDNgz8Ez8nQkjXQeO7tFHrnmOXl8PF6LvyC_wdjUjYmUjpqmot0QKiH6YUGhQxjvghagraen85NTttd-ZSmt2hgIQ7tQKaKjeCpL6waZJJ4hUBfrx5b0uu0xrAg6UTf0zNQ_TfP315-OwihntB162Fibq5fk_GD_bO-QjQUWWAk8q2coNpZJgRJo0lZJaXwCWAUcoxBe8VI6K00x41VWFWnifYXy6xZMaBNZzryy_BXZaNrGvSHUcSdyM3OZAw6YG2MV50biLWIlKpWnEyKWM63LUX0ch7bQyzCzSz0aSKOBdDTQhExXr11H-Y11L3xCM64ao3p2eAA-pUef0ut8akLypRPokYhEggGfqtf9_8PSaTQsVLx9MY1rh06nRcI5Ekz-cBsO-IMaZCKZkNfR41YjQSk22Allb__HCLfJE-x0jMt5Rzb6H4N7D-yqtztkc3508u1oJyyoWzRpIeU
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+emergence+and+successful+elimination+of+SARS-CoV-2+dominant+strains+with+increasing+epidemic+potential+in+Taiwan%27s+2021+outbreak&rft.jtitle=Heliyon&rft.au=Yang%2C+Chin-Rur&rft.au=Chang%2C+Sui-Yuan&rft.au=Gong%2C+Yu-Nong&rft.au=Huang%2C+Chung-Guei&rft.date=2023-12-01&rft.issn=2405-8440&rft.eissn=2405-8440&rft.volume=9&rft.issue=12&rft.spage=e22436&rft_id=info:doi/10.1016%2Fj.heliyon.2023.e22436&rft_id=info%3Apmid%2F38107297&rft.externalDocID=38107297
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2405-8440&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2405-8440&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2405-8440&client=summon